LMC-67606-05264
4 vaccinations
3 coded responses
38 check-ins
3 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 302 / GA
- Registered
- 2021-03-12
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-03-12
Registered in v-safe
-
2021-03-12
Dose 1 — Moderna
-
2021-03-12
Survey response — day 0, dose 1MedDRA: Lymph node pain — Feeling: Fair · Site: Pain · Muscle or body aches, Fatigue or tirednessFree text: Tender lymph nodesMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-03-13
- 2021-03-14
- 2021-03-15
- 2021-03-16
- 2021-03-17
- 2021-03-18
- 2021-03-19
- 2021-03-26
- 2021-04-02
- 2021-04-09
- 2021-04-16
-
2021-04-23
Dose 2 — Moderna
- 2021-04-23
-
2021-04-24
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain, Swelling · Headache, Muscle or body aches, Fatigue or tirednessAdult check-in
- 2021-04-25
- 2021-04-26
- 2021-04-27
- 2021-04-30
- 2021-05-07
- 2021-05-14
- 2021-05-21
- 2021-05-28
- 2021-06-04
- 2021-07-23
- 2021-10-24
-
2021-11-01
Dose 3 — Moderna
- 2021-11-09
- 2021-11-15
-
2021-11-22
Survey response — day 21, dose 3MedDRA: Conjunctivitis — Feeling: GoodFree text: Pink eyeMedDRA releases: 2024-11 · check-in free text available
- 2021-12-01
- 2021-12-06
-
2021-12-13
Survey response — day 42, dose 3MedDRA: Conjunctivitis, Eye discharge, Ocular hyperaemia — Feeling: Fair · Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: Conjunctivitis- redness and discharge in the eyeMedDRA releases: 2024-11 · check-in free text available
-
2021-12-13
Report sent to call center — day 42, dose 3Get care from a doctor or other healthcare professionalTelehealth, virtual health, or email health consultation · 1 call case(s)
- 2021-12-14
- 2022-01-31
- 2022-05-02
-
2022-09-15
Dose 4 — Moderna
- 2022-10-15
- 2022-10-20
- 2022-10-27
- 2022-12-15
- 2023-03-18
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-12 | Moderna | |
| 2 | 2021-04-23 | Moderna | |
| 3 | 2021-11-01 | Moderna | No |
| 4 | 2022-09-15 | Moderna | No |
Call center
1 call center case
1 unsuccessful
Free text
Release 5 — day 0, dose 1
Systemic reaction (other): Tender lymph nodes
Release 10 — day 21, dose 3
Symptoms: Pink eye
Release 10 — day 42, dose 3
Symptoms: Conjunctivitis- redness and discharge in the eye
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Conjunctivitis | · | · | ✓ |
| SD | Eye discharge | · | · | ✓ |
| SD | Ocular hyperaemia | · | · | ✓ |
| SRO | Lymph node pain | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release